WP
TSHA icon

Woodline Partners’s Taysha Gene Therapies TSHA Stock Holding History

Woodline Partners’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.3M Buy
513,828
+13,828
+3% +$64.3K 0.01% 791
2025
Q4 		$2.75M Hold
500,000
– – 0.01% 733
2025
Q3 		$1.64M Sell
500,000
-500,254
-50% -$1.42M 0.01% 749
2025
Q2 		$2.31M Buy
1,000,254
+142,000
+17% +$309K 0.01% 702
2025
Q1 		$1.19M Sell
858,254
-169,268
-16% -$283K 0.01% 745
2024
Q4 		$1.78M Buy
1,027,522
+28
+0% +$58 0.01% 670
2024
Q3 		$2.07M Buy
1,027,494
+1,225
+0.1% +$2.69K 0.02% 475
2024
Q2 		$2.3M Buy
+1,026,269
New +$2.99M 0.02% 409

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM